Clinical trial

Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets

NCT07412015

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2026-05-15

PhaseNA

Study timeline

Study start (actual)2026-05-15Date precision: day

Registry last updated2026-09-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

T2DM (Type 2 Diabetes Mellitus)unresolved

Interventions

treatment T (dose 1)DRUG

treatment T (dose 2)DRUG

treatment R (dose 1)DRUG

treatment R (dose 2)DRUG

Sponsors & collaborators

Chipscreen Biosciences, Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07412015 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.